Cargando…

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program

BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Moses, Tabitha E, Rhodes, Gary L, Tavakoli, Emytis, Christensen, Carl W, Amirsadri, Alireza, Greenwald, Mark K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669697/
https://www.ncbi.nlm.nih.gov/pubmed/36407024
http://dx.doi.org/10.1177/11782218221138335
_version_ 1784832176887431168
author Moses, Tabitha E
Rhodes, Gary L
Tavakoli, Emytis
Christensen, Carl W
Amirsadri, Alireza
Greenwald, Mark K
author_facet Moses, Tabitha E
Rhodes, Gary L
Tavakoli, Emytis
Christensen, Carl W
Amirsadri, Alireza
Greenwald, Mark K
author_sort Moses, Tabitha E
collection PubMed
description BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic. AIM: Determine whether SC patients’ retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features. METHODS: From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic’s standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes. RESULTS: SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (P < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics. CONCLUSIONS: Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population.
format Online
Article
Text
id pubmed-9669697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-96696972022-11-18 Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program Moses, Tabitha E Rhodes, Gary L Tavakoli, Emytis Christensen, Carl W Amirsadri, Alireza Greenwald, Mark K Subst Abuse Original Research Article BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic. AIM: Determine whether SC patients’ retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features. METHODS: From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic’s standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes. RESULTS: SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (P < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics. CONCLUSIONS: Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population. SAGE Publications 2022-11-15 /pmc/articles/PMC9669697/ /pubmed/36407024 http://dx.doi.org/10.1177/11782218221138335 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Moses, Tabitha E
Rhodes, Gary L
Tavakoli, Emytis
Christensen, Carl W
Amirsadri, Alireza
Greenwald, Mark K
Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title_full Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title_fullStr Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title_full_unstemmed Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title_short Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
title_sort predictors of retention and drug use among patients with opioid use disorder transferred to a specialty “second chance” methadone program
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669697/
https://www.ncbi.nlm.nih.gov/pubmed/36407024
http://dx.doi.org/10.1177/11782218221138335
work_keys_str_mv AT mosestabithae predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram
AT rhodesgaryl predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram
AT tavakoliemytis predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram
AT christensencarlw predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram
AT amirsadrialireza predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram
AT greenwaldmarkk predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram